Scribd Logo
Carica

Benvenuto in Scribd!

  • Asia Pacific Drug Formulation & Bioavailability Congress September 05-07, 2016 Beijing, China

    Caricato da

    Monty Karl
    85 visualizzazioni6 pagine
    Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07, 2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China. Conference Highlights: • Preformulation & Formulation • Drug Formulation Procedures • Novel Drug Delivery System & Stability Studies • Drug Product Manufacturing • Analytical Method Development • Biopharmaceutics Classification System • Bioavailability Studies & Factors Affecting Bioavailability • Nutrient & Advances In Bioavailability • Medicinal Chemistry & Traditional Medicine • Clinical Studies & Contract Research Organizations • Regulatory & Quality Management Support • Entrepreneur Investment Special Benefits: • All accepted abstracts will be published in the respective Journal • Abstracts will receive a (DOI) provided by CrossRef • Special privileges on group registrations • Opportunity to organize Workshop/Symposia • Global Exposure to your Research • Best poster competition & young researcher competitions Organising Committee members: • Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy, University in Shaqraa, Saudi Arabia. • Peng Li, Scientist in Medicine, University of California, Canada • Weiguo Dai, Scientific Director for Johnson &Johnson , USA • Sinerik Ayrapetyan, Professor in UNESCO, Armenia • Duc P. Do, Associate Professor at Chicago State University College of Pharmacy, USA • Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi Pharmaceutical Society, Saudi Arabia • M. Fawzi Mahomoodally, Professor at University of Mauritius, Mauritius. Submit us your abstract in your area of your expertise, we are sure that your presentation will add a remarkable impact to the fellow researchers. Why China? China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its market value could reach more than $158bn in 2016, and expand strongly to 2023.

    Copyright

    © © All Rights Reserved

    Formati disponibili

    PDF, TXT o leggi online da Scribd

    Hai trovato utile questo documento?

    Questo contenuto è inappropriato?

    Segnala questo documento
    Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07, 2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China. Conference Highlights: • Preformulation & Formulation • Drug Formulation Procedures • Novel Drug Delivery System & Stability Studies • Drug Product Manufacturing • Analytical Method Development • Biopharmaceutics Classification System • Bioavailability Studies & Factors Affecting Bioavailability • Nutrient & Advances In Bioavailability • Medicinal Chemistry & Traditional Medicine • Clinical Studies & Contract Research Organizations • Regulatory & Quality Management Support • Entrepreneur Investment Special Benefits: • All accepted abstracts will be published in the respective Journal • Abstracts will receive a (DOI) provided by CrossRef • Special privileges on group registrations • Opportunity to organize Workshop/Symposia • Global Exposure to your Research • Best poster competition & young researcher competitions Organising Committee members: • Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy, University in Shaqraa, Saudi Arabia. • Peng Li, Scientist in Medicine, University of California, Canada • Weiguo Dai, Scientific Director for Johnson &Johnson , USA • Sinerik Ayrapetyan, Professor in UNESCO, Armenia • Duc P. Do, Associate Professor at Chicago State University College of Pharmacy, USA • Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi Pharmaceutical Society, Saudi Arabia • M. Fawzi Mahomoodally, Professor at University of Mauritius, Mauritius. Submit us your abstract in your area of your expertise, we are sure that your presentation will add a remarkable impact to the fellow researchers. Why China? China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its market value could reach more than $158bn in 2016, and expand strongly to 2023.

    Copyright:

    © All Rights Reserved
    Scarica in formato PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    85 visualizzazioni6 pagine

    Asia Pacific Drug Formulation & Bioavailability Congress September 05-07, 2016 Beijing, China

    Caricato da

    Monty Karl
    Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07, 2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China. Conference Highlights: • Preformulation & Formulation • Drug Formulation Procedures • Novel Drug Delivery System & Stability Studies • Drug Product Manufacturing • Analytical Method Development • Biopharmaceutics Classification System • Bioavailability Studies & Factors Affecting Bioavailability • Nutrient & Advances In Bioavailability • Medicinal Chemistry & Traditional Medicine • Clinical Studies & Contract Research Organizations • Regulatory & Quality Management Support • Entrepreneur Investment Special Benefits: • All accepted abstracts will be published in the respective Journal • Abstracts will receive a (DOI) provided by CrossRef • Special privileges on group registrations • Opportunity to organize Workshop/Symposia • Global Exposure to your Research • Best poster competition & young researcher competitions Organising Committee members: • Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy, University in Shaqraa, Saudi Arabia. • Peng Li, Scientist in Medicine, University of California, Canada • Weiguo Dai, Scientific Director for Johnson &Johnson , USA • Sinerik Ayrapetyan, Professor in UNESCO, Armenia • Duc P. Do, Associate Professor at Chicago State University College of Pharmacy, USA • Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi Pharmaceutical Society, Saudi Arabia • M. Fawzi Mahomoodally, Professor at University of Mauritius, Mauritius. Submit us your abstract in your area of your expertise, we are sure that your presentation will add a remarkable impact to the fellow researchers. Why China? China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its market value could reach more than $158bn in 2016, and expand strongly to 2023.

    Copyright:

    © All Rights Reserved
    Scarica in formato PDF, TXT o leggi online su Scribd
    Segnala contenuti inappropriati
    di 6

    Asia Pacific Drug Formulation and

    Bioavailability Congress
    Beijing, China

    September 05-07, 2016

    Brochure

    Conference Secretariat
    5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA
    Ph: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499
    Email: drugformulation@conferenceseries.com, drugformulation@conferenceseries.net
    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    Invitation

    OMICS International welcomes you to attend the Asia Pacific Drug Formulation
    and Bioavailability Congress during September 05-07, 2016 at Beijing, China
    We cordially invite all the participants who are interested in sharing their
    knowledge and research in the area of Drug Formulation and Bioavailability.
    Drug Formulation 2016 anticipates more than 300 participants around the
    globe with thought provoking Keynote lectures, Oral and Poster presentations.
    The attending delegates include Editorial Board Members of related OMICS
    International Journals.
    This is an excellent opportunity for the delegates from Universities and Institutes
    to interact with the world class Scientists.
    The intending participants can confirm their participation by registering for
    the conference along with your colleagues. Avail the delegate early bird offer.
    The main theme of the conference is Advanced Drug Formulation
    perspectives for Comprehensive Bioavailability.
    Regards,
    Drug Formulation 2016 Organizing Committee

    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    About Us

    OMICS International Journals

    Key features
    User friendly/feasible website translation of your
    paper to 50 worlds leading languages
    Enhanced feature: Audio version of published paper
    Digital articles to share and explore
    Sharing option: Social networking enabled
    Authors, reviewers and editors are provided with
    scientific credits

    OMICS International Conferences

    Key features
    Presentation by renowned speakers from all over the
    world
    Poster presentations and world class exhibits
    Interactive Sessions
    Live Streaming Conferences and Meetings
    Platform for global networking
    Connecting scientific community

    700 Open Access Journals


    Scholarly Journals Index- PubMed, ISI, Scopus,
    Chemical Abstracts Service, ProQuest, Gale EBSCO
    21 Day rapid review process
    70000 Editorial Team
    7.5 Million readers and high visibility
    More than 100000
    Publication immediately after acceptance
    Quality and quick editorial, review processing

    3000+ Global Events with over 600+ Conferences,


    1200+ Symposiums and 1200+ Workshops
    15 Million unique visitors/year (36 million page
    views/year)
    Well organized scientific program
    Renowned speakers and scientists across the globe
    Poster presentations and world class exhibits
    Panel discussions and interactive sessions
    B2B meetings
    Perfect platform for Global Networking

    Special Issues

    All accepted abstracts will be published in respective OMICS International Journals


    Each abstract will be provided with digital Object Identifier by

    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    The field of Formulation and Bioavailability is growing rapidly and its development is making
    tremendous impacts in medical sciences and pharmaceuticals. The importance and significance can
    be gauged by the fact that it has made huge advancements over the course of time and is continuing
    to influence various sectors.
    Drug Formulation 2016
    Opportunity to attend the presentations delivered by eminent scientists from all over the
    world
    Selected contributions will be published in following OMICS International Journals
    Journal of Pharmaceutics & Drug Delivery Research
    Journal of Developing Drugs
    Drug Designing
    Journal of Bioavailability and Bioequivalence
    Journal of Drug Metabolism and Toxicology
    Participation in sessions on specific topics on which the conference is expected to achieve
    progress
    Global networking: In transferring and exchanging Ideas
    Conference brings together Scientific Researchers, Medical Surgeons and Physicians

    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    About Beijing

    Beijing formerly Romanized as Peking is the capital of the Peoples Republic of China and one of the most populous
    cities in the world, with a population of 19,612,368 as of 2010. The metropolis, located in northern China, is governed
    as a direct-controlled municipality under the national government, with 14 urban and suburban districts and two
    rural counties. Beijing Municipality is surrounded by Hebei Province with the exception of neighboring Tianjin
    Municipality to the southeast.
    Beijing is Chinas second largest city by urban population after Shanghai and is the countrys political, cultural,
    and educational center and home to the headquarters for most of Chinas largest state-owned companies. Beijing is a
    major transportation hub in the national highway, expressway, railway and high-speed rail network. Beijings Capital
    International Airport is the second busiest in the world by passenger traffic.

    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    About Us
    Venue
    DoubleTree by Hilton Beijing
    168 Guang An Men Wai Avenue
    Xi Cheng District
    Beijing 100055
    China
    Tel: 86-10-6338-1888

    Important Dates
    Abstract submission opens: August 05, 2015
    Registration opens: August 05, 2015
    Early bird registration: January 30, 2016
    On spot registration: September 05, 2016

    http://drugformulation-bioavailability.pharmaceuticalconferences.com/

    Potrebbero piacerti anche